Cytel’s Chief Medical Officer, Albert Kim, and Chief Scientific Officer, Yannis Jemiai discuss and demonstrate a new vision for collaboration in clinical development. Through case studies, Albert and Yannis demonstrate how Solara®, Cytel’s first-in-class platform for clinical trial strategy, enables the dialogue necessary to advance a variety of informed decisions. They evaluate critical business scenarios while considering key clinical trial design and development factors to answer common questions and ensure the best outcome for their organization.
Meet the Speakers
|
|
|
Albert Kim MD, PhD |
|
Yannis Jemiai |
|
